Detalhe da pesquisa
1.
A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators.
Pharmacogenet Genomics
; 31(3): 68-73, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33165168